• Citer

Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials.

par Major, P;Lortholary, Alain;Hon, J.;Abdi, Ehtesham;Mills, Gordon B;Menssen, H D;Yunus, F;Bell, Richard H;Body, Jean-Jacques ;Quebe-Fehling, E;Seaman, J
Référence Journal of clinical oncology, 19, 2, page (558-567)
Publication Publié, 2001-01

Article révisé par les pairs

• Détails
• Contenu

Titre:	Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials.
Auteur:	Major, P; Lortholary, Alain; Hon, J.; Abdi, Ehtesham; Mills, Gordon B; Menssen, H D; Yunus, F; Bell, Richard H; Body, Jean-Jacques; Quebe-Fehling, E; Seaman, J
Informations sur la publication:	Journal of clinical oncology, 19, 2, page (558-567)
Statut de publication:	Publié, 2001-01
Sujet CREF:	Cancérologie
MeSH keywords:	Adult
	Aged
	Diphosphonates -- therapeutic use
	Female
	Humans
	Hypercalcemia -- drug therapy -- etiology
	Imidazoles -- therapeutic use
	Male
	Middle Aged
	Neoplasms -- complications
	Randomized Controlled Trials as Topic
Note générale:	Journal Article
	Meta-Analysis
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:pmid/11208851